Lomitapide: a novel drug for homozygous familial hypercholesterolemia

Novel Drug

Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia

Case Medical Research ◽

10.31525/ct1-nct04233918 ◽

2020 ◽

Author(s):

Keyword(s):

Pediatric Patients ◽

Efficacy And Safety ◽

Faculty Opinions recommendation of Evinacumab for homozygous familial hypercholesterolemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.738519803.793577892 ◽

2020 ◽

Author(s):

Carlos Aguilar-Salinas

Keyword(s):

Homozygous familial hypercholesterolemia in a young woman with dual gene mutations of low-density lipoprotein receptor and proprotein convertase subtilisin/kexin type 9

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2020.01.009 ◽

2020 ◽

Vol 14 (2) ◽

pp. 192-196

Author(s):

Patrizia Suppressa ◽

Concetta Carbonara ◽

Natasha Scialpi ◽

Alessandro Ciavarella ◽

Carlo Sabbà

Keyword(s):

Young Woman ◽

Low Density Lipoprotein ◽

Gene Mutations ◽

Density Lipoprotein ◽

Low Density ◽

Lipoprotein Receptor ◽

Proprotein Convertase ◽

Density Lipoprotein Receptor

PLAQUE BURDEN IN TWO ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: TURNING BACK THE CLOCK WITH AGGRESSIVE LDL-C LOWERING

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)01485-6 ◽

2021 ◽

Vol 77 (18) ◽

pp. 126

Author(s):

Nick Nurmohamed ◽

Rens Reeskamp ◽

Michiel Bom ◽

Nils Planken ◽

Roel Driessen ◽

...

Keyword(s):

Plaque Burden ◽

Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia

The Journal of Lipid Research ◽

10.1016/s0022-2275(20)37137-6 ◽

1997 ◽

Vol 38 (10) ◽

pp. 2071-2078

Author(s):

A D Marais ◽

R P Naoumova ◽

J C Firth ◽

C Penny ◽

C K Neuwirth ◽

...

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Diagnostic value of coronary flow reserve determined by echo dipyridamole stress in homozygous familial hypercholesterolemia

Revista Española de Cardiología (English Edition) ◽

10.1016/j.rec.2020.09.003 ◽

2020 ◽

Author(s):

Francesco Sbrana ◽

Emilio M. Pasanisi ◽

Beatrice Dal Pino ◽

Federico Bigazzi ◽

Tiziana Sampietro

Keyword(s):

Coronary Flow Reserve ◽

Coronary Flow ◽

Diagnostic Value ◽

Flow Reserve ◽

Dipyridamole Stress

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2021.02.002 ◽

2021 ◽

Vol 15 (2) ◽

pp. 379-380

Author(s):

Alpo Vuorio ◽

Frederick Raal ◽

Reinhard Klingel ◽

Petri T. Kovanen

Keyword(s):

Lipoprotein Apheresis

THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)01800-3 ◽

2021 ◽

Vol 77 (18) ◽

pp. 441

Author(s):

Eric Bruckert ◽

Sonia Caprio ◽

Albert Wiegman ◽

Min-Ji Charng ◽

Cézar A. Zárate-Morales ◽

...

Keyword(s):

Children And Adolescents ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study

Mipomersen, a First-in-Class Apolipoprotein B Synthesis Inhibitor, Lowers Lipoprotein (a) in Patients with Homozygous Familial Hypercholesterolemia

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2010.03.055 ◽

2010 ◽

Vol 4 (3) ◽

pp. 221 ◽

Cited By ~ 2

Author(s):

William C. Cromwell ◽

Raul D. Santos ◽

Dirk J. Blom ◽

David A. Marais ◽

Robin H. Lachmann ◽

...

Keyword(s):

Apolipoprotein B ◽

Synthesis Inhibitor ◽

Lipoprotein A

Evolocumab in the management of children <10 years of age affected by homozygous familial hypercholesterolemia

Atherosclerosis ◽

10.1016/j.atherosclerosis.2021.03.026 ◽

2021 ◽

Author(s):

Paola Sabrina Buonuomo ◽

Gerarda Mastrogiorgio ◽

Giovanna Leone ◽

Ippolita Rana ◽

Michaela Veronika Gonfiantini ◽

...

Keyword(s):